Category: Latest News
-

CNA Financial Falls Short of Q4 Forecasts as Underwriting Performance Softens
CNA Financial Corporation (NYSE:CNA) reported fourth-quarter core income of $317 million, or $1.16 per diluted share, missing analysts’ expectations of $1.19 per share. Revenue totaled $2.79 billion, also below the consensus forecast of $2.88 billion. Shares of the insurer slipped 0.11% in after-hours trading following the release. Compared with the same period a year earlier,…
-

Biofrontera Reports Positive Phase 3 Data for Ameluz in Actinic Keratosis
Biofrontera Inc. (NASDAQ:BFRI) said on Monday that its Phase 3 clinical study of Ameluz photodynamic therapy (PDT) successfully achieved its primary endpoint in the treatment of actinic keratoses affecting the extremities, neck and trunk. Despite the encouraging trial outcome, shares of the micro-cap company—currently trading around $0.82 and valued at roughly $9.56 million—have fallen 8.37%…
-

Momentus Shares Jump After NASA Deal to Advance In-Orbit Servicing
Momentus (NASDAQ:MNTS) shares surged about 30% after the company announced it has signed a Space Act Agreement with NASA to jointly develop new in-orbit servicing and space operations capabilities. Under the agreement, the commercial space company will deploy a NASA CubeSat into low Earth orbit to demonstrate rendezvous and proximity operations, as well as formation…
-

Gold Advances as Precious Metals Rally Builds Ahead of Crucial U.S. Data
Gold prices climbed close to 1% on Monday, extending gains from last week after a sharp 4% surge on Friday, as investors positioned themselves ahead of a series of delayed U.S. economic releases. The yellow metal traded firmly throughout the session, adding to a strong run that lifted prices to their highest levels in several…
-

Wall Street Faces Potential Volatility as Key Economic Reports Approach: Dow Jones, S&P, Nasdaq, Futures
U.S. stock index futures are signaling a largely flat start to trading on Monday, suggesting markets may struggle to find clear direction after the strong rebound seen at the end of last week. Investors appear to be pausing to digest recent market swings, which included a sharp, technology-led selloff midweek followed by a powerful recovery…
-

FedEx-Advent Consortium Moves to Acquire InPost for $9.2bn as Shares Jump
A consortium led by FedEx Corporation (NYSE:FDX) and private equity group Advent has agreed terms to acquire Polish parcel locker operator InPost SA (AS:INPST) in a transaction valuing the company at around €7.79 billion ($9.22 billion), according to a joint statement released on Monday. Under the proposal, the consortium is offering €15.60 per InPost share,…
-

Block Plans Workforce Reduction of Up to 10% as It Pushes for Leaner Operations
Block Inc (NYSE:XYZ) is preparing to cut as much as 10% of its global workforce—around 1,100 roles—as part of a broader effort to rein in costs and streamline operations, according to a report from Bloomberg. The Jack Dorsey-led payments group has begun informing hundreds of employees that their positions may be at risk as part…
-

Kroger Set to Appoint Former Walmart Executive Greg Foran as CEO, WSJ Reports
Kroger Company (NYSE:KR) is preparing to name former Walmart (NASDAQ:WMT) executive Greg Foran as its next chief executive officer, according to a report by the Wall Street Journal citing people familiar with the matter. The U.S. supermarket chain is expected to announce the appointment as early as Monday, bringing to a close a search that…
-

Tegna Shares Climb After Trump Voices Support for Nexstar Deal
Tegna Inc (NYSE:TGNA) shares advanced roughly 5% in premarket trading on Monday after U.S. President Donald Trump publicly backed a proposed merger between Tegna and Nexstar Media Group (NASDAQ:NXST). Trump expressed his support for the potential transaction on Saturday, saying he favours the combination, which would result in the largest operator of regional television stations…
-
Novo Nordisk Shares Surge as Hims Drops $49 Weight-Loss Pill Under Regulatory Pressure
Novo Nordisk (NYSE:NVO) rallied strongly on Monday after telehealth provider Hims Hers Health (NYSE:HIMS) withdrew its recently launched $49 compounded weight-loss pill over the weekend, following pushback from Novo Nordisk and the U.S. Food and Drug Administration. Novo Nordisk shares climbed more than 8% in Copenhagen trading by 04:48 ET (09:48 GMT), while its U.S.-listed…